Fitbit is involved in a new research study. Too bad they selected the wrong patients.

Fitbit company and the Dana-Faber Cancer Institute are teaming together to investigate the relationship of breast cancer reoccurrence and weight loss. Too bad they did not include the one group of women who undergo weight loss surgery to successively achieve substantial and long lasting weight loss reduction.

This Breast Cancer Weight Loss Study (BWEL) [is a 2 year study that] will include 32,000 overweight or obese women who have been diagnosed with early stage breast cancer. Each participant will receive FitBit devices: a fitness tracker that collects activity and heart rate information throughout the day; a scale that tracks weight, BMI, lean body mass and body percent fat, as well as access to proprietary software “which offers personalized video-based exercise experiences on mobile devices.” All these will link to an online dashboard to monitor progress and help the women stay on track.

http://acsh.org/news/2016/06/29/new-investigation-will-examine-breast-cancer-recurrence-post-weight-loss/